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S U M M A R Y
Ancient and historical tuberculosis (TB) can be recognized by its typical paleopathology in human
remains. Using paleomicrobiology, it is possible to detect many more individuals infected with TB but
with no visible lesions. Due to advances inmolecular analysis over the past two decades, it is clear that TB
was widespread in humans from the Neolithic period and has remained so until the present day. Past
human populations were associated with different lineages of the Mycobacterium tuberculosis complex,
thereby elucidating early humanmigrations. Using paleomicrobiology, it is possible to detect individuals
infected with TB who are also co-infected with other bacteria or parasites. TB is also found in hosts with
co-morbidities such as neoplasms, or metabolic disorders such as rickets and scurvy. In well-preserved
human skeletal or mummiﬁed tissue, whole genome sequencing has detected individuals with multiple
infections of different M. tuberculosis strains. Such studies put modern ﬁndings into context and
emphasize the importance of human population density in such circumstances.
 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Recognition of ancient and historical TB by paleopathology
Paleopathologists are readily able to identify the characteristic
appearance of Pott’s disease that results from tuberculosis (TB) of
the spine. There is damage to the spinal column that results in
kyphosis, associated with damage to the spinal column and
paralysis in the lower limbs.1,2 Symptoms of TB also include a
chronic or ‘cold’ abscess, periosteal reactive lesions on tubular
bones, hypertrophic osteoarthropathy, and osteomyelitis, but
these conditions are not speciﬁc.3–6 Brucellosis and chronic
inﬂammation can also cause bony changes, so further tests are
required for conﬁrmation of infection. In addition, it is estimated
that skeletal TB occurs in only 3–5% of untreated cases, so it is clear
that any diagnosis that relies solely on gross morphology will
detect only a small fraction of ancient TB infections.7
In recent years, additional techniques have been used to detect
past pathological conditions, including infectious diseases. Micro-
scopic techniques, such as ﬂuorescent con-focal microscopy,
enable the ﬁne detail of pathogenic lesions to be assessed, but
may not provide deﬁnitive identiﬁcation of the infecting agent in
the absence ofmacroscopic bone changes.8 Computed tomography* .
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).(CT) and micro-CT scanning have largely replaced traditional
radiographs. However, although these can identify pathological
conditions, the high level of radiation can inactivate ancient DNA
(aDNA), so it is important to optimize the protocols and to follow
some simple rules to minimize any aDNA damage.9
2. Detection and characterization of Mycobacterium
tuberculosis ancient DNA
The development of molecular diagnostic methods, including
DNA ampliﬁcation via PCR, has enabled anthropologists and
paleopathologists to examine historical and archaeological speci-
mens for the presence of pathogen aDNA and other molecular
markers. Ancient TB and leprosy were the ﬁrst human infectious
diseases to be conﬁrmed by PCR.10–12 Initially there was much
concern about contamination with modern DNA, coming princi-
pally from those working on human and other mammalian
material.13,14 Although it is easier to prevent such contamination
when investigating an obligate human pathogen with no known
environmental reservoir,15,16 many studies have incorporated
independent veriﬁcation from other laboratories, including the use
of totally different techniques to identify pathogen molecular
markers, such as bacterial cell wall lipids.17,18 It is now clear that
TBwas very common in the past and that typical paleopathology is
the exception rather than the rule.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
H.D. Donoghue / International Journal of Infectious Diseases 56 (2017) 176–180 177The introduction of PCR enabled aDNA from theMycobacterium
tuberculosis complex to be detected and also opened theway to the
direct characterization of past strains and lineages. The clinical
importance of modern TB and the need for rapid diagnosis led to
the development of PCR-based diagnostics, and these were soon
applied to M. tuberculosis aDNA. Speciﬁc short repetitive
sequences, such as IS6110 and IS1081, have been used as targets
for DNA ampliﬁcation, although care is needed to ensure the
primer speciﬁcity.19,20 Some skeletal and mummiﬁed tissues were
sufﬁciently well preserved to enable characterization based on
synonymous single nucleotide polymorphisms (SNPs).21 Spoligo-
typing, based on spacer regions in the repetitive DR locus, also
enabled characterization of strains and lineages.22 Spoligotyping,
SNP analysis, and other polymorphisms were used in an early
biomolecular study of some well-preserved 18th century naturally
mummiﬁed human remains from the town of Va´c in Hungary that
were infected with M. tuberculosis.23,24 As there were contempo-
raneous church and civic archives, it was possible to draw
conclusions about the epidemiology of the disease in this
population.25
The sequencing of the M. tuberculosis genome enabled the
recognition of current M. tuberculosis lineages, revealing the
association of different human populations with different lineages
ofM. tuberculosis.26 It also led to an understanding of the probable
origin of the differentM. tuberculosis lineages and their geographi-
cal distribution.27,28 It was soon realized that the identiﬁcation of
different lineages of M. tuberculosis aDNA could be used as an
indicator of past human migrations. An early example of the
recognition of different lineages was the study of TB in ancient
Egypt. M. tuberculosis aDNA was detected in the early dynastic (ca
3500–2650 BC), Middle Kingdom to Second Intermediate Period
(ca 2100–1550 BC), the New Kingdom and the Late Period (ca
1450–500 BC).29 M. tuberculosis aDNA was found in many bones
that had no pathological lesions. Spoligotyping indicated that both
M. tuberculosis and Mycobacterium africanum were present. The
strains ofM. tuberculosis included those inwhich the TbD1 deletion
had occurred, but also strains that were TbD1-intact. However,
there was no evidence of Mycobacterium bovis.30 Indeed, M. bovis
aDNA has been found only in a community of Siberian pastoralists,
who overwintered in huts that also contained their animals.31,32
However, human remains close to a Peruvian river that ﬂows into
the Paciﬁc Ocean were found to contain anM. tuberculosis complex
strain that was most closely related to Mycobacterium pinnipedii,
suggesting that sea mammals may have been a source of infection
in that community (see Section 6).33
3. Detection of ancient tuberculosis via other biomolecules
Several studies have reported the use of matrix-assisted laser
desorption/ionization tandem time-of-ﬂight mass spectrometry
(MALDI-TOF MS) for the detection of ancient proteins or
peptides.34 Mycocerosic acids and other speciﬁc components of
the M. tuberculosis cell wall were detected in the ribs of
49 individuals from the 19th and 20th century Coimbra Identiﬁed
Skeletal Collection, half of those being historically documented
with TB infections.17 Other organic chemical methods, such as
ﬂuorescence high performance liquid chromatography (HPLC), or
selected ion monitoring (SIM) negative ion chemical ionization
(NICI) gas chromatography mass spectrometry (GCMS) have both
the sensitivity and speciﬁcity to directly detect and quantify
ancient mycobacterial cell wall lipid biomarkers, without the need
for ampliﬁcation.18,35
The analysis of ancient microbial proteins has been less
productive than studies based on M. tuberculosis aDNA or cell
wall lipids due to their lower speciﬁcity, but it was predicted that
MALDI-TOF MS should be able to detect host signatures speciﬁcto infection.34 In 2012 the protein expression proﬁle of buccal
swabs from two 500-year-old Andeanmummies was obtained by
the use of shotgun proteomics.36 Several proteins were detected
that are not normally present in blood or saliva, but are
consistent with a host immune response to infectious disease.
In addition, a probable pathogenic Mycobacterium was detected.
It appears that ancient microbial proteins are less informative
than other biomarkers, as in a recent study of seven samples from
18th century Hungarian mummiﬁed lung, chest, and pleural
tissues where TB was prevalent, shotgun proteomics identiﬁed
only four peptides with unique matches to the M. tuberculosis
complex.37
4. Tuberculosis in relation to early humans
The earliest case of an M. tuberculosis complex infection was
recognized in a Pleistocene bison that was excavated from the
Natural Trap Cave in Wyoming, USA. The environmental
conditions enabled excellent preservation of aDNA and other
molecular markers. Evidence of TB was obtained from just
below the articulating surface of a metacarpal bone.38 The
early ﬁndings were queried but a subsequent analysis of
mycobacterial cell wall lipid molecular biomarkers conﬁrmed
the diagnosis.39
Before the development of molecular diagnostic techniques it
was assumed that, in the Neolithic period, domesticated animals
were the source of TB that subsequently infected humans.40
However, recent genomic studies have conﬁrmed that
M. tuberculosis is more ancestral than M. bovis,41 so it is believed
now that TB became common in the Neolithic period due to animal
domestication supporting larger human populations, thereby
facilitating the spread of infection. Using both aDNA and
mycobacterial cell wall lipid analysis,M. tuberculosiswas detected
in a submerged 9000-year-old village off the eastern Mediterra-
nean coast,42,43 but the associated animal bones were negative.44
Limited molecular evidence of TB was also obtained from an
11 000-year-old pre-domestication site (8800–8300 BCE cal.) and
an early domestication site (8200–7600 BCE cal.) in Syria,45 but yet
again, the animal bones provided no evidence of TB. There has been
speculation that TB may have occurred even earlier in hominids
such as Homo erectus,46 although the paleopathology in this case
was disputed.47 Recently it has been suggested that the
M. tuberculosis complex may be yet more ancient than has
previously been believed48 and that Neanderthals were possibly
infected.49
The association of TB with population density is due to the
combination of the aerosol route of infection ofM. tuberculosis and
the fact that it is an obligate pathogen. It appears that early
lineages of M. tuberculosis are less virulent than the predominant
strains today and this may have resulted from the necessity for the
pathogen to survive in small, scattered human populations until
therewas an opportunity for transmission. However,more virulent
strains of M. tuberculosis have emerged in ancient centres of
population where they still persist.50 It is believed that the
M. tuberculosis complex evolved from smooth colony strains
termed ‘Mycobacterium prototuberculosis’51 that subsequently
gained additional persistence and virulence mechanisms.52,53 The
modern smooth colony strains in the M. tuberculosis complex are
classiﬁed asMycobacterium canettii, are found in the horn of Africa
and may have an environmental reservoir. They are very diverse,
experience horizontal gene transfer, yet share a highly conserved
core genomewith other members of theM. tuberculosis complex.53 [1_TD$DIFF]
Infections are rare in the local human population and there is little
evidence of person-to-person spread.54 In contrast, the other
members of the M. tuberculosis complex show no evidence of
horizontal gene transfer. They appear to have emerged via an
H.D. Donoghue / International Journal of Infectious Diseases 56 (2017) 176–180178evolutionary bottleneck followed by clonal expansion,27,41,55 and
modern M. tuberculosis lineages are associated with different
human populations.56
5. Past co-infections and co-morbidities
Pulmonary TB was widespread in the past, so it is unsurprising
that M. tuberculosis aDNA can be found in association with other
infections and non-infectious conditions. However, it is difﬁcult to
distinguish between active and latent disease. Injury or other
infections lower host resistance, thereby allowing latent TB to re-
activate. Similarly, the very young or old are more susceptible to
infection. In contrast, worms and parasites were common in past
human societies and these are known to have a developmental and
regulatory role in the host immune response.57 There are examples
of human skeletal remains that demonstrate paleopathology that
indicates co-infections, for example of TB and leprosy. In central
Europe, M. tuberculosis and Mycobacterium leprae aDNA have been
detected in the same specimens.58,59 This led to the suggestion that
leprosy declined as urbanization and thereby the level of TB
increased.59 The population data suggest that this is a feasible
theory.60 TB has also been associated with malaria in Ancient
Egypt61 and with Chagas disease in 10th century northern Peru.62
M. tuberculosis and Leishmania spp have been detected as co-
infections in Early Christian Nubia and Middle Kingdom ancient
Egypt.63
Co-morbidities include cancer andmetabolic disorders such as
rickets and scurvy. These can be detected by paleopathology of
skeletal material, including cribra orbitalia (pitting of the eye
sockets), which is interpreted as indicating nutritional or
metabolic stress. Vitamin deﬁciency and malnutrition will
decrease host resistance to infection and may result in re-
activation of latent infection.64,65 An example is shown by a study
of the Cross Bones burial site in Southwark, London, UK, dating
from the mid-19th century that contained a majority of adult
women and infants. The site was notorious for prostitution and
the burial ground was for those who were destitute. Many of the
human remains show clear signs of infectious and metabolic
diseases, but none were identiﬁed by paleopathology as having
TB. However, a biomolecular analysis showed that 27% of
individuals in this population were positive for M. tuberculosis
aDNA.66 Other conditions in this population identiﬁed by
paleopathology have included syphilis, Paget’s disease, prostate
cancer, healed rickets, scoliosis, and osteoarthritis. Another
cancer-like condition that has been found in association with
active TB is Langerhans cell histiocytosis. Such a case was
discovered in one of the Va´c 18th centurymummies – a 4-year-old
boy who was infected with M. tuberculosis.67 This demonstrates
the complexities in past populations where many factors
contribute to the ﬁnal outcome.
6. Insights from whole genome sequencing (WGS)
Advances in sequencing and instrumentation have enabled
whole genomes of historical strains of M. tuberculosis to be
determined. However, most historical and archaeological speci-
mens will include high levels of environmental microbial DNA.
Therefore, various enrichment strategies have been devised, such
as capture of targets by probes or microarrays, or selective capture
of damaged DNA molecules using probe-based, solid phase or
whole genome target enrichment.68,69 The use of WGS provides
additional conﬁrmation of the authenticity of aDNA by the analysis
of DNA damage patterns.68,69 A next generation sequencing (NGS)
approach that included hybridization capture of speciﬁc regions of
interest enabled a detailed genotype to be identiﬁed from an
individual buried in a 19th century church crypt in Leeds, UK.70 Inthe Peruvian study described in Section 2, a selection of skeletal
samples from pre- and post-contact New World sites were
examined, initially using screening based on a capture assay
designed for ﬁve M. tuberculosis genes. Three samples showed
convincing evidence ofM. tuberculosisDNA andwere subsequently
examined by whole genome analysis. DNA libraries were treated
with uracil DNA glycosylase to remove and repair damaged
nucleotides, and were subsequently used for full genome
hybridization capture.33 In a different strategy, Chan et al. used
a metagenomic approach, with open-ended sequencing of aDNA,
without target-speciﬁc ampliﬁcation or enrichment.71 This was
possible due to the excellent preservation of the 18th century
naturally mummiﬁed tissue from Va´c, Hungary. The source of the
tissue, a young woman aged 28 years at the time of death, was
infected with two different strains of M. tuberculosis, both similar
to the Haarlem and Erdman lineages. In a further study of eight
Hungarian 18th-century mummies, a majority were infected with
two M. tuberculosis genotypes and one individual contained three
genotypes.72 Overall, 14 genotypes were obtained, all belonging to
M. tuberculosis lineage 4.
The phenomenon of mixed strain M. tuberculosis infection has
recently been highlighted as an increasing problem today, as itmay
affect the outcomes of treatment for infected individuals and
inﬂuence the impact of population-level interventions against
TB.73,74 Modern studies have emphasized the impact of HIV co-
infection, antimicrobial therapy, and drug resistance on this
phenomenon, but the data from the pre-antibiotic era highlight the
importance of human population density in this interaction
between host and pathogen.
7. Recent ﬁndings from epigenetics and transcriptomics
An exciting new area of study is emerging in the ﬁeld of physical
anthropology—that of epigenetics and transcriptomics. The
epigenome is viewed as a collection of regulatory layers that
control when, where, and how genes are turned on or off.75
Epigenetic changes, such as methylation patterns, have been
detected in ancient humans and other mammals.76 This opens the
way to the analysis of regulatory changes underlying adaptation
and species divergence. This approach was used in the analysis of
methylation data from the hair of a 4000-year-old paleo-Eskimo,
where the extent of methylation indicated that this individual
probably died in his 50s.77 It is possible to selectively enrich
microbial DNA from a background of vertebrate host DNA,78
although this is less of a problem when examining historical or
ancient material. Recent studies using a methylated binding
domains (MBD)-based enrichment method79 have shown that
when aDNA is preserved under favourable conditions, methylation
can survive over 45 000 years, whereas in less favourable
conditions such as warmer regions, its half-life can be as short
as approximately 1500 years.75 However, MBD enrichment
appears to be appropriate only for the analysis of very well
preserved sampleswhere DNA fragmentation and deamination are
limited.79
M. tuberculosis transcriptomics is currently an active ﬁeld of
study, but the techniques have not yet been applied to historical
or ancient human remains.80,81 This is clearly an area where
important insights should be obtained, provided suitable well-
preserved specimens containing sufﬁcient M. tuberculosis aDNA
are available for analysis, such as historical remains from the
permafrost or possibly the 18th century Hungarian Va´c mum-
mies. The combination of epigenetics, proteomics, and tran-
scriptomics should throw light on the differences in gene
expression and virulence between M. tuberculosis strains and
lineages.82,83
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The detection of M. tuberculosis aDNA more than 20 years ago
led to the new ﬁeld of paleomicrobiology. It was initially viewed as
a useful method to conﬁrm the presence of TB in human remains
with typical paleopathology. However, it rapidly became clear that
visible paleopathology was the exception and that TBwas far more
prevalent than had been assumed previously. Also, additional
paleopathological indicators of M. tuberculosis infection were
thereby authenticated. It became possible to identify different
M. tuberculosis genetic lineages and to associate these with early
human populations, thus providing data on migrations. The use of
M. tuberculosis aDNA and cell wall lipids has allowed past
M. tuberculosis infection to be studied alongside other markers
of migration and diet, such as stable isotope analysis.
M. tuberculosis ancient biomolecules have also provided insights
into the interpretation of modern ﬁndings, such as infections
involving mixed lineages of M. tuberculosis. Perhaps the greatest
contribution of M. tuberculosis aDNA research is that it enables
genetic changes to be studied in real time and the rate of
evolutionary change to be directly calibrated. This demonstrates
the value of ‘blue skies’ research, as we now appreciate the extent
to which paleomicrobiology can enhance our understanding of
both ancient and modern infection.
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